They focused on a mutant gene, SLC12A5, and found that SLC12A5 activation could promote cell proliferation and inhibit apoptosis, thus potentially promoting oncogenesis and demonstrating the biclonal origin of CRC cases (46). Here, SLC12A5 is linked to colorectal carcinoma.